<!DOCTYPE html >
<html lang="en">
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p112" style="overflow: hidden; position: relative; background-color: white; width: 433px; height: 649px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_112{left:4px;top:233px;letter-spacing:-0.1px;}
#t2_112{left:4px;top:78px;letter-spacing:-0.3px;}
#t3_112{left:5px;top:629px;letter-spacing:-0.4px;}
#t4_112{left:59px;top:40px;letter-spacing:-1.2px;word-spacing:4.7px;}
#t5_112{left:59px;top:56px;letter-spacing:-1.2px;word-spacing:-1.5px;}
#t6_112{left:52px;top:73px;letter-spacing:-1px;}
#t7_112{left:59px;top:73px;letter-spacing:-1px;}
#t8_112{left:59px;top:88px;letter-spacing:-1px;word-spacing:-0.1px;}
#t9_112{left:52px;top:106px;letter-spacing:-1px;}
#ta_112{left:59px;top:106px;letter-spacing:-1px;word-spacing:2.9px;}
#tb_112{left:59px;top:121px;letter-spacing:-1px;word-spacing:1.5px;}
#tc_112{left:59px;top:136px;letter-spacing:-1px;word-spacing:4.1px;}
#td_112{left:59px;top:152px;letter-spacing:-1px;word-spacing:-0.2px;}
#te_112{left:52px;top:169px;letter-spacing:-1px;}
#tf_112{left:59px;top:169px;letter-spacing:-1px;word-spacing:-1.5px;}
#tg_112{left:224px;top:169px;}
#th_112{left:233px;top:169px;letter-spacing:-0.9px;word-spacing:-1.5px;}
#ti_112{left:59px;top:184px;letter-spacing:-1px;}
#tj_112{left:43px;top:219px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#tk_112{left:52px;top:237px;letter-spacing:-0.9px;word-spacing:-0.3px;}
#tl_112{left:52px;top:254px;letter-spacing:-1px;word-spacing:-2px;}
#tm_112{left:52px;top:271px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#tn_112{left:52px;top:289px;letter-spacing:-1px;word-spacing:-0.1px;}
#to_112{left:52px;top:317px;letter-spacing:-1px;word-spacing:-0.1px;}
#tp_112{left:52px;top:334px;letter-spacing:-1px;}
#tq_112{left:59px;top:334px;letter-spacing:-1px;word-spacing:3.5px;}
#tr_112{left:59px;top:350px;letter-spacing:-1px;word-spacing:-0.2px;}
#ts_112{left:52px;top:367px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#tt_112{left:43px;top:402px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#tu_112{left:43px;top:420px;letter-spacing:-1px;word-spacing:-0.1px;}
#tv_112{left:43px;top:437px;letter-spacing:-1px;word-spacing:4px;}
#tw_112{left:43px;top:452px;letter-spacing:-1px;word-spacing:-0.1px;}
#tx_112{left:43px;top:470px;letter-spacing:-1px;word-spacing:5.4px;}
#ty_112{left:43px;top:485px;letter-spacing:-1px;word-spacing:-0.2px;}
#tz_112{left:43px;top:502px;letter-spacing:-1px;}
#t10_112{left:95px;top:502px;letter-spacing:-1px;word-spacing:3.5px;}
#t11_112{left:43px;top:518px;letter-spacing:-1px;word-spacing:2.1px;}
#t12_112{left:43px;top:533px;letter-spacing:-1px;word-spacing:-0.1px;}
#t13_112{left:43px;top:550px;letter-spacing:-1px;}
#t14_112{left:104px;top:550px;letter-spacing:-1px;word-spacing:2.7px;}
#t15_112{left:43px;top:566px;letter-spacing:-1px;word-spacing:-0.1px;}

.s1_112{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(156,100,158);
}

.s2_112{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(35,31,32);
}

.s3_112{
	FONT-SIZE: 39.7px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(255,255,255);
}

.s4_112{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.s5_112{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Symbol_j9;
	color: rgb(35,31,32);
}

.s6_112{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.t.m0_112{
	-webkit-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-ms-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-moz-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-o-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
}

</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts112" type="text/css" >

@font-face {
	font-family: Symbol_j9;
	src: url("fonts/Symbol_j9.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed-Bold_j0;
	src: url("fonts/Helvetica-Condensed-Bold_j0.woff") format("woff");
}

@font-face {
	font-family: AllerDisplay_lq;
	src: url("fonts/AllerDisplay_lq.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed_ix;
	src: url("fonts/Helvetica-Condensed_ix.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg112Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg112" style="-webkit-user-select: none;"><object width="433" height="649" data="112/112.svg" type="image/svg+xml" id="pdf112" style="width:433px; height:649px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div id="t1_112" class="t m0_112 s1_112">O Guia do Jovem Internista </div>
<div id="t2_112" class="t m0_112 s2_112">2016</div>
<div id="t3_112" class="t s3_112">110</div>
<div id="t4_112" class="t s4_112">de paracentese, íleus maciço com distensão marcada de ansas in-</div>
<div id="t5_112" class="t s4_112">testinais. INR elevado ou trombocitopenia, não são contraindicações.</div>
<div id="t6_112" class="t s4_112">• </div>
<div id="t7_112" class="t s4_112">Análises iniciais: leucócitos com contagem diferencial, proteínas to-</div>
<div id="t8_112" class="t s4_112">tais com albumina, e gradiente sero-ascítico de albumina</div>
<div id="t9_112" class="t s4_112">• </div>
<div id="ta_112" class="t s4_112">Análises complementares: exames culturais em hemocultura aeró-</div>
<div id="tb_112" class="t s4_112">bio e anaeróbio à cabeceira, coloração de Gram, citologia (suspeita </div>
<div id="tc_112" class="t s4_112">de malignidade), amilase (supeita de causa pancreática), triglicéri-</div>
<div id="td_112" class="t s4_112">dos (se ascite quilosa).</div>
<div id="te_112" class="t s4_112">• </div>
<div id="tf_112" class="t s4_112">Gradiente sero-ascítico de albumina </div>
<div id="tg_112" class="t s5_112">±</div>
<div id="th_112" class="t s4_112">1.1g/dL - sinal de hipertensão </div>
<div id="ti_112" class="t s4_112">portal.</div>
<div id="tj_112" class="t s6_112">• Tratamento</div>
<div id="tk_112" class="t s4_112">• Medidas Gerais:</div>
<div id="tl_112" class="t s4_112">- Tratar a doença de base (nomeadamente, com abstinência alcoólica)</div>
<div id="tm_112" class="t s4_112">- Restrição de sódio (2g/dia)</div>
<div id="tn_112" class="t s4_112">- Restrição de água se natrémia &lt;120 mmol/L</div>
<div id="to_112" class="t s4_112">• Terapêutica diurética: (em dose única de manhã)</div>
<div id="tp_112" class="t s4_112">- </div>
<div id="tq_112" class="t s4_112">Espironolactona - 100 a 200mg/dia (máx. 400mg/dia, aumento da </div>
<div id="tr_112" class="t s4_112">dose 7-7 dias)</div>
<div id="ts_112" class="t s4_112">- Furosemida 40 a 160mg/dia</div>
<div id="tt_112" class="t s4_112">No 1º episódio de ascite - iniciar 100mg de espironolactona; </div>
<div id="tu_112" class="t s4_112">Na ascite recorrente - espironolactona 100mg e furosemida 40mg.</div>
<div id="tv_112" class="t s4_112">Aumentar cada 7 dias mantendo proporção 100:40 se objectivos não </div>
<div id="tw_112" class="t s4_112">atingidos (máximo 400mg/ 160mg)</div>
<div id="tx_112" class="t s4_112">Se intolerância à espironolactona (ginecosmastia dolorosa) substituir </div>
<div id="ty_112" class="t s4_112">por amiloride (10-40mg/d)</div>
<div id="tz_112" class="t s6_112">Objectivo:</div>
<div id="t10_112" class="t s4_112">perda de peso de 1Kg/semana, na 1ª semana; depois 2kg/</div>
<div id="t11_112" class="t s4_112">semana nas semanas seguintes; máximo de 0,5kg/dia, se doente sem </div>
<div id="t12_112" class="t s4_112">edema, ou 1kg/dia, se presença de edema.</div>
<div id="t13_112" class="t s6_112">Monitorizar:</div>
<div id="t14_112" class="t s4_112">alterações electrolíticas, desidratação, hipotensão e insu-</div>
<div id="t15_112" class="t s4_112">ficiência renal.</div>

<!-- End text definitions -->


</div>
</body>
</html>
